Sodium oxybate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Sodium oxybate or gamma-hydroxybutyrate (GHB) is sold under the brand name Xyrem is a restricted prescription drug licensed for the prevention of cataplexy (sudden, brief episodes of loss of muscle strength) and narcolepsy.[1][2]

Prescription sodium oxybate and Xyrem have significant differences from the illegal street drug also known as GHB.[3]

Side effects[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ "Sodium oxybate Uses, Side Effects & Warnings". Drugs.com. Retrieved September 25, 2020.
  2. ↑ "Sodium Oxybate: MedlinePlus Drug Information". medlineplus.gov. Retrieved September 25, 2020.
  3. ↑ Carter, Lawrence P.; Pardi, Daniel; Gorsline, Jane; Griffiths, Roland R. (September 1, 2009). "Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): differences in characteristics and misuse". Drug and alcohol dependence. 104 (1–2): 1–10. doi:10.1016/j.drugalcdep.2009.04.012. ISSN 0376-8716. PMC 2713368. PMID 19493637.

adverse reaction Any unintended or unwanted response to a treatment, whether in a clinical trial or licensed treatment. May be minor or serious.

Retrieved from "https://me-pedia.org/w/index.php?title=Sodium_oxybate&oldid=240087"